About us
AARDEX Group is the pioneer and world leader in developing, manufacturing, and marketing MEMS™, Medication Event Monitoring System, which measures, analyzes and facilitates patients' adherence to prescribed drug dosing regimens in clinical trials.
AARDEX Group has a decade of experience in routine clinical practice in providing the monitors, information technology, and expertise for enhancing patient adherence and maintaining long term persistence with prescribed ambulatory pharmacotherapy.
AARDEX Group is led by an international management team with extensive experience in key areas including medicine and therapeutics, biostatistics, engineering, production, regulatory affairs, sales and marketing, and customer support. Our people go the extra mile to ensure quality, integrity and, above all, customer satisfaction.
AARDEX Group's products are currently marketed in over 40 different countries. We provide responsive customer service, notwithstanding the great diversity of therapeutic fields in which our products are used.
- Head offices:
-
AARDEX Group Ltd.
Avenue de la Gare 29
1950 Sion, Switzerland - Subsidiary:
-
- Visé, Belgium
- Bank details:
-
Banque Cantonale du Valais
1951 Sion, Switzerland
- Swift Code:
- BCVSCH2LXXX
- IBAN CHF:
- CH03 0076 5001 0021 7391 0
- IBAN EUR:
- CH78 0076 5001 0021 7420 9
- IBAN USD:
- CH94 0076 5001 0021 7440 6
- VAT:
- CHE-112.158.298 TVA
